257 related articles for article (PubMed ID: 29898433)
1. Electrochemotherapy with cisplatin or bleomycin in head and neck squamous cell carcinoma: Improved effectiveness of cisplatin in HPV-positive tumors.
Prevc A; Niksic Zakelj M; Kranjc S; Cemazar M; Scancar J; Kosjek T; Strojan P; Sersa G
Bioelectrochemistry; 2018 Oct; 123():248-254. PubMed ID: 29898433
[TBL] [Abstract][Full Text] [Related]
2. Electrochemotherapy of radioresistant head and neck squamous cell carcinoma cells and tumor xenografts.
Zakelj MN; Prevc A; Kranjc S; Cemazar M; Todorovic V; Savarin M; Scancar J; Kosjek T; Groselj B; Strojan P; Sersa G
Oncol Rep; 2019 Mar; 41(3):1658-1668. PubMed ID: 30628709
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of cisplatin chemotherapy combined with fractionated radiotherapy regimen in HPV-positive and HPV-negative experimental pharyngeal squamous cell carcinoma.
Kranjc Brezar S; Prevc A; Niksic Zakelj M; Brozic A; Cemazar M; Strojan P; Sersa G
Sci Rep; 2020 Jan; 10(1):1563. PubMed ID: 32005919
[TBL] [Abstract][Full Text] [Related]
4. Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer.
Spanos WC; Nowicki P; Lee DW; Hoover A; Hostager B; Gupta A; Anderson ME; Lee JH
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1137-46. PubMed ID: 19917928
[TBL] [Abstract][Full Text] [Related]
5. Electrochemotherapy in non-melanoma head and neck cancers: a retrospective analysis of the treated cases.
Campana LG; Mali B; Sersa G; Valpione S; Giorgi CA; Strojan P; Miklavcic D; Rossi CR
Br J Oral Maxillofac Surg; 2014 Dec; 52(10):957-64. PubMed ID: 25183266
[TBL] [Abstract][Full Text] [Related]
6. Electroporation Enhances Bleomycin Efficacy in Cats with Periocular Carcinoma and Advanced Squamous Cell Carcinoma of the Head.
Spugnini EP; Pizzuto M; Filipponi M; Romani L; Vincenzi B; Menicagli F; Lanza A; De Girolamo R; Lomonaco R; Fanciulli M; Spriano G; Baldi A
J Vet Intern Med; 2015; 29(5):1368-75. PubMed ID: 26192904
[TBL] [Abstract][Full Text] [Related]
7. Treatment response of HPV-positive and HPV-negative head and neck squamous cell carcinoma cell lines.
Nagel R; Martens-de Kemp SR; Buijze M; Jacobs G; Braakhuis BJ; Brakenhoff RH
Oral Oncol; 2013 Jun; 49(6):560-6. PubMed ID: 23578372
[TBL] [Abstract][Full Text] [Related]
8. Efficiency of electrochemotherapy with reduced bleomycin dose in the treatment of nonmelanoma head and neck skin cancer: Preliminary results.
Groselj A; Bosnjak M; Strojan P; Krzan M; Cemazar M; Sersa G
Head Neck; 2018 Jan; 40(1):120-125. PubMed ID: 29130624
[TBL] [Abstract][Full Text] [Related]
9. Electrochemotherapy for the treatment of recurrent head and neck cancers: preliminary results.
Mevio N; Bertino G; Occhini A; Scelsi D; Tagliabue M; Mura F; Benazzo M
Tumori; 2012; 98(3):308-13. PubMed ID: 22825505
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus in head and neck carcinomas: prevalence, physical status and relationship with clinical/pathological parameters.
Badaracco G; Venuti A; Morello R; Muller A; Marcante ML
Anticancer Res; 2000; 20(2B):1301-5. PubMed ID: 10810439
[TBL] [Abstract][Full Text] [Related]
11. HPV induction of APOBEC3 enzymes mediate overall survival and response to cisplatin in head and neck cancer.
Conner KL; Shaik AN; Ekinci E; Kim S; Ruterbusch JJ; Cote ML; Patrick SM
DNA Repair (Amst); 2020 Mar; 87():102802. PubMed ID: 31981740
[TBL] [Abstract][Full Text] [Related]
12. Acid sphingomyelinase activity as an indicator of the cell stress in HPV-positive and HPV-negative head and neck squamous cell carcinoma.
Gerle M; Medina TP; Gülses A; Chu H; Naujokat H; Wiltfang J; Açil Y
Med Oncol; 2018 Mar; 35(4):58. PubMed ID: 29564578
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck.
Ringström E; Peters E; Hasegawa M; Posner M; Liu M; Kelsey KT
Clin Cancer Res; 2002 Oct; 8(10):3187-92. PubMed ID: 12374687
[TBL] [Abstract][Full Text] [Related]
14. Dose-Modifying Factor of Radiation Therapy with Concurrent Cisplatin Treatment in HPV-Positive Squamous Cell Carcinoma: A Preclinical Study.
Prevc A; Kranjc S; Cemazar M; Todorovic V; Zegura B; Novak M; Filipic M; Flezar MS; Kirbis IS; Rotter A; Brozic A; Zakelj MN; Poljak M; Hosnjak L; Groselj B; Strojan P; Sersa G
Radiat Res; 2018 Jun; 189(6):644-651. PubMed ID: 29652621
[TBL] [Abstract][Full Text] [Related]
15. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus associated XPF deficiency increases alternative end joining and cisplatin sensitivity in head and neck squamous cell carcinoma.
Zuo N; Ma L; Liu T; Hu W; Luo Y; Meng H; Ren Q; Deng Y; Wei L; Liu Q
Oral Oncol; 2023 May; 140():106367. PubMed ID: 36996606
[TBL] [Abstract][Full Text] [Related]
17. Statistical analysis of human papillomavirus in a subset of upper aerodigestive tract tumors.
Liu H; Li J; Diao M; Cai Z; Yang J; Zeng Y
J Med Virol; 2013 Oct; 85(10):1775-85. PubMed ID: 23861229
[TBL] [Abstract][Full Text] [Related]
18. Detection of human papillomavirus (HPV) type 6, 16 and 18 in head and neck squamous cell carcinomas by in situ hybridization.
Cerovac Z; Sarcević B; Kralj Z; Ban J
Neoplasma; 1996; 43(3):185-94. PubMed ID: 8841506
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and tolerance of electrochemotherapy as palliative therapy for patients with head and neck cancer and malignant melanoma and its relation to early skin reaction.
Caballero-Borrego M; Coll S; Navarrete P
Braz J Otorhinolaryngol; 2024; 90(1):101365. PubMed ID: 38006727
[TBL] [Abstract][Full Text] [Related]
20. Special Issue about Head and Neck Cancers: HPV Positive Cancers.
Economopoulou P; Kotsantis I; Psyrri A
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
